{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:45:11Z","timestamp":1777675511670,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T17:45:14Z","timestamp":1403027114000},"page":"4537-4542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB\/c mice"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-9978","authenticated-orcid":false,"given":"Shikha","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-7760","authenticated-orcid":false,"given":"Prachiti","family":"Afley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir K.","family":"Dohre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandita","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.06.012_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tvjl.2009.04.010","article-title":"Pathogenesis of bovine brucellosis","volume":"184","author":"Carvalho Neta","year":"2010","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0010","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.143.10.3330","article-title":"Temporal development of protective cell-mediated and humoral immunity in BALB\/c mice infected with Brucella abortus","volume":"143","author":"Araya","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0015","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/infdis\/jiq171","article-title":"B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus","volume":"203","author":"Goenka","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","article-title":"Biological properties of RB51; a stable rough strain of Brucella abortus","volume":"28","author":"Schurig","year":"1991","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0025","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/jcm.32.4.1065-1066.1994","article-title":"Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51","volume":"32","author":"Stevens","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1086\/375595","article-title":"Human illness associated with use of veterinary vaccines","volume":"37","author":"Berkelman","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0040","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00018-006-6311-4","article-title":"Brucella as a biological weapon","volume":"63","author":"Pappas","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0045","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.vaccine.2008.03.064","article-title":"Potentiation of an anthrax DNA vaccine with electroporation","volume":"26","author":"Luxembourg","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.06.012_bib0055","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1745-7580-6-S1-S5","article-title":"Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN","volume":"6","author":"He","year":"2010","journal-title":"Immunome Res"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0060","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/IAI.71.9.4857-4861.2003","article-title":"A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB\/c mice","volume":"71","author":"Onate","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0065","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0070","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0080","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0085","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1016\/S0264-410X(02)00269-4","article-title":"Electroporation improves the efficacy of DNA vaccines in large animals","volume":"20","author":"Babiuk","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0090","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.vaccine.2003.09.053","article-title":"In vivo electroporation improves immune responses to DNA vaccination in sheep","volume":"22","author":"Scheerlinck","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/icb.1997.60","article-title":"DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors","volume":"75","author":"Ramsay","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0105","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.69.6.4174-4176.2001","article-title":"Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette\u2013Guerin against tuberculosis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0110","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0264-410X(96)00264-2","article-title":"Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit","volume":"15","author":"Barnett","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0115","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/IAI.69.5.3041-3047.2001","article-title":"Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0120","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1242\/jeb.00642","article-title":"Prime-boost strategies for malaria vaccine development","volume":"206","author":"Dunachie","year":"2003","journal-title":"J Exp Biol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/2049-632X.12079","article-title":"Identification of a protective protein from stationary-phase exoproteome of Brucella abortus","volume":"70","author":"Jain","year":"2014","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10482-008-9292-5","article-title":"Th1-type immune response to infection by pYV-cured phoP\u2013phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model","volume":"95","author":"Kumar","year":"2009","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0135","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0145","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0150","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1\u2013Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-8518-7-1","article-title":"Evaluation of recombinant invasive, non-pathogenic Escherichia coli as a vaccine vector against the intracellular pathogen, Brucella","volume":"7","author":"Harms","year":"2009","journal-title":"J Immune Based Ther Vaccines"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0160","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1016\/j.vaccine.2009.06.075","article-title":"Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7\/L12 and BLS fusion antigen of Brucella","volume":"27","author":"Zhao","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0165","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/IAI.70.5.2535-2543.2002","article-title":"Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu, Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type","volume":"70","author":"He","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.imbio.2008.11.016","article-title":"Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB\/c mice","volume":"214","author":"Cabrera","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-11-69","article-title":"Influenza viral vectors expressing the Brucella OMP16 or L7\/L12 proteins as vaccines against B. abortus infection","volume":"11","author":"Tabynov","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0180","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.vaccine.2013.06.013","article-title":"Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB\/c mice","volume":"31","author":"Riquelme-Neira","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.68.1.257-263.2000","article-title":"Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro","volume":"68","author":"Eze","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevImmunol.v26.i5.30","article-title":"Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection","volume":"26","author":"Baldwin","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0195","first-page":"458","article-title":"Cytokine production in the murine response to Brucella infection or immunization with antigenic extracts","volume":"80","author":"Zhan","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0200","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1128\/IAI.00856-13","article-title":"Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB\/c mice","volume":"81","author":"Gu","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1574-695X.2001.tb00536.x","article-title":"Immune control of Brucella abortus 2308 infections in BALB\/c mice","volume":"32","author":"Murphy","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0210","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/iai.64.7.2782-2786.1996","article-title":"Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms","volume":"64","author":"Zhan","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2004.12.009","article-title":"Interferon-gamma associated cytokines and chemokines produced by spleen cells from Brucella-immune mice","volume":"30","author":"Paranavitana","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0220","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","article-title":"Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice","volume":"103","author":"Murphy","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S0100-879X1998000100010","article-title":"The role of T cell subsets and cytokines in the regulation of intracellular bacterial infection","volume":"31","author":"Oliveira","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0230","doi-asserted-by":"crossref","first-page":"686919","DOI":"10.1155\/2013\/686919","article-title":"CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis","volume":"2013","author":"Yingst","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0235","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.00761-12","article-title":"Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B, cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice","volume":"80","author":"Vitry","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.012_bib0240","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2009.08.097","article-title":"The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams","volume":"27","author":"Estein","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:30Z","timestamp":1759400430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14008019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":48,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X14008019"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}